Joel Greenblatt’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,385
Closed -$279K – 1924
2026
Q2
$279K Sell
2,385
-759
-24% -$76.2K ﹤0.01% 1667
2026
Q1
$290K Buy
+3,144
New +$296K ﹤0.01% 1611
2025
Q2
– Sell
-6,043
Closed -$272K – 1714
2025
Q1
$272K Buy
+6,043
New +$285K ﹤0.01% 1399

Other funds holding MIRM

Joel Greenblatt's MIRM Position: Q3 2026 in Review

Joel Greenblatt sold out of Mirum Pharmaceuticals (MIRM) in Q3 2026, closing a stake of 2,385 shares — an estimated $279K sold.

Joel Greenblatt first reported a position in MIRM in Q1 2025 and held it in 3 quarters. The position peaked at $290K in Q1 2026. 317 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Joel Greenblatt reported no remaining Mirum Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Joel Greenblatt sold 2,385 Mirum Pharmaceuticals shares in Q3 2026, an estimated $279K.
  • Joel Greenblatt first reported a position in Mirum Pharmaceuticals in Q1 2025 and held it in 3 quarters.
  • Joel Greenblatt's Mirum Pharmaceuticals position peaked at $290K in Q1 2026.
  • 317 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.